These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38982480)

  • 61. Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC.
    Li J; Yan T; Wu X; Ke X; Li X; Zhu Y; Yang J; Li Z
    BMC Cancer; 2021 Nov; 21(1):1205. PubMed ID: 34772357
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis.
    Wang S; Chen X; Qiao T
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846802
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Targeting STAT3 potentiates CDK4/6 inhibitors therapy in head and neck squamous cell carcinoma.
    Dong L; Liu C; Sun H; Wang M; Sun M; Zheng J; Yu X; Shi R; Wang B; Zhou Q; Chen Z; Xing B; Wang Y; Yao X; Mei M; Ren Y; Zhou X
    Cancer Lett; 2024 Jul; 593():216956. PubMed ID: 38735381
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancer.
    Umar SM; Kashyap A; Kahol S; Mathur SR; Gogia A; Deo SVS; Prasad CP
    Exp Cell Res; 2020 Nov; 396(1):112282. PubMed ID: 32919954
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The transcription factor FOXM1 regulates the balance between proliferation and aberrant differentiation in head and neck squamous cell carcinoma.
    Roh V; Hiou-Feige A; Misetic V; Rivals JP; Sponarova J; Teh MT; Ferreira Lopes S; Truan Z; Mermod M; Monnier Y; Hess J; Tolstonog GV; Simon C
    J Pathol; 2020 Jan; 250(1):107-119. PubMed ID: 31465124
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Single-Cell Molecular Profiling of Head and Neck Squamous Cell Carcinoma Reveals Five Dysregulated Signaling Pathways Associated With Circulating Tumor Cells.
    Stucky A; Viet CT; Aouizerat BE; Ye Y; Doan C; Mundluru T; Sedhiazadeh P; Sinha UK; Chen X; Zhang X; Li SC; Cai J; Zhong JF
    Cancer Control; 2024; 31():10732748241251571. PubMed ID: 38869038
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SUZ12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma.
    Wu Y; Hu H; Zhang W; Li Z; Diao P; Wang D; Zhang W; Wang Y; Yang J; Cheng J
    J Cell Mol Med; 2018 Jul; 22(7):3582-3594. PubMed ID: 29667751
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Downregulation of LINC00460 decreases STC2 and promotes autophagy of head and neck squamous cell carcinoma by up-regulating microRNA-206.
    Xue K; Li J; Nan S; Zhao X; Xu C
    Life Sci; 2019 Aug; 231():116459. PubMed ID: 31075234
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The interaction of interleukin-8 and PTEN inactivation promotes the malignant progression of head and neck squamous cell carcinoma via the STAT3 pathway.
    Xu Q; Ma H; Chang H; Feng Z; Zhang C; Yang X
    Cell Death Dis; 2020 May; 11(5):405. PubMed ID: 32471980
    [TBL] [Abstract][Full Text] [Related]  

  • 70. VIRMA promotes the progression of head and neck squamous cell carcinoma by regulating
    Zhu C; Cheng Y; Yu Y; Zhang Y; Ren G
    Biomol Biomed; 2024 Sep; 24(5):1244-1257. PubMed ID: 38577917
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comprehensive analysis of the expression and prognosis for CDCAs in head and neck squamous cell carcinoma.
    Wu ZH; Fang M; Zhou Y
    PLoS One; 2020; 15(7):e0236678. PubMed ID: 32716971
    [TBL] [Abstract][Full Text] [Related]  

  • 72. LINC00958-MYC positive feedback loop modulates resistance of head and neck squamous cell carcinoma cells to chemo- and radiotherapy in vitro.
    Huang S; Zhan Z; Li L; Guo H; Yao Y; Feng M; Deng J; Xiong J
    Onco Targets Ther; 2019; 12():5989-6000. PubMed ID: 31413594
    [TBL] [Abstract][Full Text] [Related]  

  • 73. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
    Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
    Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
    [TBL] [Abstract][Full Text] [Related]  

  • 74. miR-34a-5p functions as a tumor suppressor in head and neck squamous cell cancer progression by targeting Flotillin-2.
    Li X; Zhao S; Fu Y; Zhang P; Zhang Z; Cheng J; Liu L; Jiang H
    Int J Biol Sci; 2021; 17(15):4327-4339. PubMed ID: 34803501
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Loss of TP63 Promotes the Metastasis of Head and Neck Squamous Cell Carcinoma by Activating MAPK and STAT3 Signaling.
    Lakshmanachetty S; Balaiya V; High WA; Koster MI
    Mol Cancer Res; 2019 Jun; 17(6):1279-1293. PubMed ID: 30910837
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinoma.
    Muhammad N; Bhattacharya S; Steele R; Phillips N; Ray RB
    Clin Cancer Res; 2017 Jun; 23(12):3120-3128. PubMed ID: 27965308
    [No Abstract]   [Full Text] [Related]  

  • 77. CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
    Wu Z; Zhu Z; Wu W; Hu S; Cao J; Huang X; Xie Q; Deng C
    Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3143-3156. PubMed ID: 38507078
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma.
    Yang P; Huang G; Li Y; Yu L; Yin Z; Li Q
    Sci Rep; 2024 Apr; 14(1):9824. PubMed ID: 38684755
    [TBL] [Abstract][Full Text] [Related]  

  • 79. FOSL1 promotes metastasis of head and neck squamous cell carcinoma through super-enhancer-driven transcription program.
    Zhang M; Hoyle RG; Ma Z; Sun B; Cai W; Cai H; Xie N; Zhang Y; Hou J; Liu X; Chen D; Kellogg GE; Harada H; Sun Y; Wang C; Li J
    Mol Ther; 2021 Aug; 29(8):2583-2600. PubMed ID: 33794365
    [TBL] [Abstract][Full Text] [Related]  

  • 80. FAP is a prognostic marker, but not a viable therapeutic target for clinical translation in HNSCC.
    Liu J; Ouyang Y; Xia Z; Mai W; Song H; Zhou F; Shen L; Chen K; Li X; Zhuang SM; Liao J
    Cell Oncol (Dordr); 2024 Apr; 47(2):623-638. PubMed ID: 37856075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.